Side effects of cocaine abuse: Multiorgan toxicity and pathological consequences

Current Medicinal Chemistry

Volumn 19, Issue 33, 2012, Pages 5624-5646

  Riezzo, I ^a   Fiore, C ^a   De Carlo, D ^a   Pascale, N ^a   Neri, M ^a   Turillazzi, E ^a   Fineschi, V ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Cardiovascular toxicity; Cocaine induced hepatotoxicity; Cocaine toxicity; Cocaine related renal injury; Local and systemic effects; Prenatal exposure; Pulmonary toxicity; Stress oxidative

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM CHANNEL; CATECHOLAMINE; CATECHOLAMINE TRANSPORTER; COCAINE; COCAINE DERIVATIVE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N HYDROXYNORCOCAINE; NORADRENALIN; NORCOCAINE; NORCOCAINE NITROXIDE; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; SODIUM; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADRENERGIC NERVE; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ARRHYTHMOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BRAIN MALFORMATION; BRAIN TOXICITY; CARDIOTOXICITY; CARDIOVASCULAR MALFORMATION; COCAINE DEPENDENCE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY; DEPOLARIZATION; GASTROINTESTINAL TOXICITY; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; INHALATION; KIDNEY FAILURE; LIVER TOXICITY; LUNG FUNCTION; LUNG TOXICITY; MITOCHONDRIAL TOXICITY; MYOCARDITIS; NEPHROTOXICITY; NERVE ENDING; NONHUMAN; OXIDATIVE STRESS; PRENATAL EXPOSURE; PROGENY; SMOKING; SNIFFING; SODIUM TRANSPORT; VASOCONSTRICTION;

ANIMALS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; KIDNEY; LIVER; LUNG; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84871337750     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803988893     Document Type: Article

References (466)

1. Lange, L. B.; Hillis, D. Cardiovascular complications of cocaine use. N. Engl. J. Med., 2001, 345(5), 351-358.
2. Karch, S. B. Cocaine: history, use and abuse. J. R. Soc. Med., 1999, 92(8), 393-397.
3. Warner EA. Cocaine abuse. Ann. Intern. Med., 1993, 119(3), 226-235.
4. Haim, D. Y.; Lippmann, M. L.; Goldberg, S. K.; Walkenstein, M. D. The pulmonary complications of crack cocaine: a comprehensive review. Chest, 1995, 107(1), 233-240.
5. Shannon, M. Clinical toxicity of cocaine adulterants. Ann. Emerg. Med., 1988, 17(11), 1243-1247.
6. Casale, J.; Klein, R. Illicit production of cocaine. Forensic Science Review, 1993, 5, 95-107.
7. Duenas, C.; Torres, C. A. Toxicidad pulmonar inducida por cocaína. Revista De Neumología, 1999, 11, 45-57.
8. Karch, S. B. The pathology of drug abuse, 2nd ed.; CRC Press: Bosa Raton FL, 1996.
9. Fleming, J. A.; Byck, R.; Barash, P. G. Pharmacology and therapeutic applications of cocaine. Anesthesiology, 1990, 73(3), 518-531.
10. Pellinen, P.; Kulmala, L.; Konttila, J.; Auriola, S.; Pasanen, M.; Juvonen, R. Kinetic characteristic of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Arch. Toxicol., 2000, 74(9), 511-520.
11. Di Paolo, N.; Fineschi, V.; Di Paolo, M.; Wetly, C. V.; Garosi, G.; Del Vecchio, M. T.; Bianciardi, G. Kidney vascular damage and cocaine. Clin. Nephrol., 1997, 47(5), 298-303.
12. White, S. M.; Lambe, CJ. The pathophysiology of cocaine abuse. J. Clin. Forensic Med., 2003, 10(1), 27-39.
13. Koob, G. F.; Le Moal, M. Drug abuse: hedonic homeostatic dysregulation. Science, 1997, 278(5335), 52-58.
14. Siegel, A. J.; Mendelson, J. H.; Sholar, M. B.; McDonald, J. C.; Lewandrowski, K. B.; Lipinska, I.; Ridker, P. M.; Tofler, G. H. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrogen. Am. J. Cardiol., 2002, 89(9), 1133-1135.
15. Somlyo, A. P.; Somlyo, A. V. Signal transduction and regulation in smooth muscle. Nature, 1994, 372(6503), 231-236.
16. Lattanzio, F. A. Jr.; Tiangco, D.; Osgood, C; Beebe, S.; Kerry, J.; Hargrave, B. Y. Cocaine increases intracellular calcium and reactive oxygen species, depolarizes mitochondria, and activates genes associated with heart failure and remodeling. Cardiovasc. Toxicol., 2005, 5(4), 377-390.
17. Bashkatova, V.; Meunier, J.; Vanin, A.; Maurice, T. Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine. Ann. N Y. Acad. Sci., 2006, 1074, 632-642.
18. Dietrich, J. B.; Mangeol, A.; Revel, M. O.; Burgun, C; Aunis, D.; Zwiller, J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology, 2005, 48(7), 965-974.
19. Lipton, J. W.; Gyawali, S.; Borys, E. D.; Koprich, J. B.; Ptaszny, M.; McGuire, S. O. Prenatal cocaine administration increases glutathione and alphatocopherol oxidation in fetal rat brain. Brain Res. Dev. Brain Res., 2003, 147(1-2), 77-84.
20. Macedo, D. S.; de Vasconcelos, S. M.; dos Santos, R. S.; Aguiar, L. M.; Lima, V. T.; Viana, G. S.; de Sousa, F. C. Cocaine alters catalase activity in prefrontal cortex and striatum of mice. Neurosci. Lett., 2005, 387(1), 53-56.
21. Belissimo, M. I.; Amado, D.; Abdalla, D. S.; Ferreira, E. C.; Cavalheiro, E. A.; Naffah-Mazzacoratti, M. G. Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats. Epilepsy Res., 2001, 46(2), 121-128.
22. Freitas, R. M.; Vasconcelos, S. M.; Souza, F. C; Viana, G. S.; Fonteles, M. M. Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats. FEBS J., 2005, 272(6), 1307-1312.
23. Poon, H. F.; Abdullah, L.; Mullan, M. A.; Mullan, M. J.; Crawford, F. C. Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem. Int., 2007, 50(1), 69-73.
24. Barros, D. O.; Xavier, S. M.; Barbosa, CO.; Silva, R. F.; Maia, F. D.; Oliveira, A. A.; Freitas, R. M.; Takahashi, R. N. Effects of the vitamin E in catalase activities in hippocampus after status epilepticus induced by pilocarpine in Wistar rats. Neurosci. Lett., 2007, 416(3), 227-230.
25. Konzen, J. P.; Levine, S. R.; Garcia, J. H. Vasospasm and thrombus formation as possible mechanism of stroke related to alkaloidal cocaine. Stroke, 1995, 26(6), 1114-1118.
26. Krendel, D. A.; Ditter, S. M.; Frankel, M. R.; Ross, W. K. Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology, 1990, 40(7), 1092-1094.
27. Fredericks, R. K.; Lefkowitz, D. S.; Challa, V. R.; Troots, B. T. Cerebral vasculitis associated with cocaine abuse. Stroke, 1991, 22(11), 1437-1439.
28. Scully, RE.; Mark, E. J.; McNeely, W. F.; Ebeling, S. H.; Phillips, L. D. Case records of Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1997. A 74-year-old man with progressive cough, dyspnea, and pleural thickening. N Engl. J. Med., 1997, 336(26), 1895-1903.
29. Diez-Tejedor, E.; Frank, A.; Gutierrez, M.; Barreiro, P. Encephalopathy and biopsy-proven cerebrovascular inflammatory changes in a cocaine abusers. Eur. J. Neurol., 1998, 5(1), 103-107.
30. Kumar, P. D.; Smith, H. R. Cocaine-related vasculitis causing upper-limb peripheral vascular disease. Ann. Intern. Med., 2000, 133(11), 923-924.
31. Spittell, J. A. Jr.; Spittell, P. C. Cocaine-related vasculitis causing upper-limb peripheral vascular disease. Ann. Intern. Med., 2001, 135(9), 843.
32. Gertner, E.; Hamlar, D. Necrotizing granulomatous vasculitis associated with cocaine use. J. Rheumatol., 2002, 29(8), 1795-1797.
33. Ruiz-Martinez, J.; Villanua, J.; Recondo, J. Vasculitis caused by toxic agents: diagnosis and follow up by magnetic resonance angiography. Rev Neurol., 2004, 38(5), 496.
34. Gericke, O. L. Suicide by ingestion of amphetamine sulphate. JAMA, 1945, 128, 1098-1099.
35. Brust, J. C.; Richter, R. W. Stroke associated with cocaine abuse? N. Y. State J. Med., 1977, 77(9), 1473-1475.
36. Tapia, J. F.; Schumacher, J. M. Case records of the Massachussets General Hospital. Weekly clinicopathological exercises. Case 27-1993. A 32-year-old man with the sudden onset of a right-sided headache and left hemiplegia and hemianesthesia. N Engl. J. Med., 1993, 329(2), 117-124.
37. Nolte, K. B.; Brass, L. M.; Fletterick, C. F. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology, 1996, 46(5), 1291-1296.
38. Nolte, K. B.; Gelman, B. B. Intracranial hemorrhage associated with cocaine abuse. Arch. Pathol. Lab. Med., 1989, 113(7), 812-813.
39. Boghdadi, M. S.; Henning, RJ. Cocaine: pathophysiology and clinical toxicology. Heart Lung, 1997, 26(6), 466-483.
40. Muir, J. K.; Ellis, E. F. Cocaine potentiates the blood pressure and cerebral blood flow response to norepinephrine in rats. Eur. J. Pharmacol., 1993, 249(3), 287-292.
41. Green, R. M.; Kelly, K. M.; Gabrielsen, T.; Levine, S. R, Vanderzant, C. Multiple intracerebral hemorrhages after smoking "crack" cocaine. Stroke, 1990, 21(6), 957-962.
42. Oyesiku, N. M.; Colohan, A. R, Barrow, D. L.; Reisner, A. Cocaine induced aneurysmal rupture: an emergent factor in the natural history of intracranial aneurysms? Neurosurgery, 1993, 32(4), 518-525.
43. Konkol, R. J.; Erickson, B. A.; Doerr, J. K.; Hoffman, R. G.; Madden, J. A. Seizures induced by the cocaine metabolite benzoylecgonine in rats. Epilepsia, 1992, 33(3), 420-427.
44. Ye, J. H.; Ren, J.; Krnjević, K.; Liu, P. L., McArdle, J. J. Cocaine and lidocaine have additive inhibitory effects on the GABAA current of acutely dissociated hippocampal pyramidal neurons. Brain Res., 1999, 821(1), 26-32.
45. Dhuna, A.; Pascual-Leone, A.; Langendorf, F. Chronic, habitual cocaine abuse and kindling-induced epilepsy: a case report. Epilessia, 1991, 32(6), 890-894.
46. Dhuna, A.; Pascual-Leone, A.; Langendorf, F.; Anderson, D. C. Epileptogenic properties of cocaine in humans. Neurotoxicology, 1991, 12(3), 621-626.
47. Itzhak, Y.; Martin, J. L. Cocaine-induced kindling is associated with elevated NMDA receptor binding in discrete mouse brain regions. Neuropharmacology, 2000, 39(1), 32-39.
48. Daras, M.; Tuchman, A. J.; Koppel, B. S.; Samkoff, L. M.; Weitzner, I.; Marc, J. Neurovascular complication of cocaine. Acta Neurol. Scand., 1994, 90(2), 124-129.
49. Bonime, W. The myth of masochism. J. Am. Acad. Psychoanal, 1995, 23(1), 33-46.
50. Catalano, G.; Catalano, M. C.; Rodriguez, R. Dystonia associated with crack cocaine use. South Med. J., 1997, 90(10), 1050-1052.
51. Riley, S. C.; James, C, Gregory, D.; Dingle, H.; Cadger, M. Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction, 2001, 96(7), 1035-1047.
52. Supervìa, A.; Llobera, J.; Cuadrado, E.; del Baño, F. Choreathetoid movements after crack abuse: "crack dancing". Med. Clin. (Barc.), 2006, 126(14), 555.
53. Kamath, S.; Bajaj, N. Crack dancing in the United Kingdom: apropos a video case presentation. Mov. Disord., 2007, 22(8), 1190-1191.
54. Cardoso, F. E.; Jankovic, J. Cocaine-related movement disorders. Mov. Disord., 1993, 8(2), 175-178.
55. Mash, D. C, Ouyang, Q.; Pablo, J.; Izenwasser, S.; Jo, E.; Basile, M. J.; Druid, H. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons: neuroplasticity or pathway to Parkinson's disease. Unreported. Abstract presented to 2001 Society for Neuroscience meeting.
56. Gerfen, C. R, Engber, T. M.; Mahan, L. C.; Susel, Z.; Chase, T. N.; Monsma, F. J. Jr.; Sibley, D. R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 1990, 250(4986), 1429-1432.
57. Brami-Cherrier, K.; Valjent, E.; Garcia, M.; Pagès, C.; Hipskind, R. A.; Caboche, J. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J. Neurosci., 2002, 22(20), 8911-8921.
58. Yan, Z.; Feng, J.; Fienberg, A. A.; Greengard, P. D (2) dopamine receptors induce mitogen-activated protein kinase and cAMP response elementbinding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. USA, 1999, 96(20), 11607-11612.
59. Hernandez-Lopez, S.; Tkatch, T.; Perez-Garci, E.; Galarraga, E.; Bargas, J.; Hamm, H.; Surmeier, D. J. D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J. Neurosci., 2000, 20(24), 8987-8995.
60. Beaulieu, J. M.; Sotnikova, T. D.; Yao, W. D.; Kockeritz, L.; Woodgett, J. R.; Gainetdinov, R. R.; Caron, M. G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. USA, 2004, 101(14), 5099-5104.
61. Caine, S. B.; Thomsen, M.; Gabriel, K. I.; Berkowitz, J. S.; Gold, L. H.; Koob, G. F.; Tonegawa, S.; Zhang, J.; Xu, M. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J. Neurosci., 2007, 27(48), 13140-13150.
62. Welter, M.; Vallone, D.; Samad, T. A.; Meziane, H.; Usiello, A.; Borrelli, E. Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc. Natl. Acad. Sci. USA, 2007, 104(16), 6840-6845.
63. Self, D. W.; Barnhart, W. J.; Lehman, D. A.; Nestler, E. J. Opposite modulation of cocaine-seeking behavior by D1-and D2-like dopamine receptor agonists. Science, 1996, 271(5255), 1586-1589.
64. Alleweireldt, A. T.; Weber, S. M.; Kirschner, K. F.; Bullock, B. L.; Neisewander, J. L. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl.), 2002, 159(3), 284-293.
65. Khroyan, T. V.; Platt, D. M.; Rowlett, J. K.; Spealman, R. D. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology (Berl.), 2003, 168(1-2), 124-131.
66. Carlezon, W. A. Jr.; Duman, R. S.; Nestler, E. J. The many faces of CREB. Trends Neurosci., 2005, 28(8), 436-445.
67. Lu, L.; Koya, E.; Zhai, H.; Hope, B. T.; Shaham, Y. Role of ERK in cocaine addiction. Trends Neurosci., 2006, 29(12), 695-703.
68. Hollander, J. A.; Im, H. I.; Amelio, A. L.; Kocerha, J.; Bali, P.; Lu, Q.; Willoughby, D.; Wahlestedt, C.; Conkright, M. D.; Kenny, P. J. Striatal microRNA controls cocaine intake through CREB signalling. Nature, 2010, 466(7303), 197-202.
69. Brami-Cherrier, K.; Valjent, E.; Hervè, D.; Darragh, J.; Corvol, J. C.; Pages, C.; Arthur, S. J.; Girault, J. A.; Caboche, J. Parsing molecular and behavioral effects of cocaine in mitogen-and stress-activated protein kinase-1-deficient mice. J. Neurosci., 2005, 25(49), 11444-11454.
70. Miller, C. A.; Marshall, J. F. Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron., 2005, 47(6), 873-884.
71. Choi, K. H.; Whisler, K.; Graham, D. L.; Self, D. W. Antisense-induced reduction in nucleus accumbens cyclic AMP response element binding protein attenuates cocaine reinforcement. Neuroscience, 2006, 137(2), 373-383.
72. Corvol, J. C.; Valjent, E.; Pascoli, V.; Robin, A.; Stipanovich, A.; Luedtke, R. R.; Belluscio, L.; Girault, J. A.; Hervè, D. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology, 2007, 32(5), 1109-1121.
73. Bailey, A.; Metaxas, A.; Yoo, J. H.; McGee, T.; Kitchen, I. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm. Eur. J. Neurosci., 2008, 28(4), 759-770.
74. Wetli, C. V.; Fishbain, D. A. Cocaine-induced psychosis and sudden death in recreational cocaine users. J. Forensic Sci., 1985, 30(3), 873-880.
75. Staley J, Basile M, Wetli C, et al.: Differential regulation of the dopamine transporter in cocaine overdose deaths. In: Harris LS: NIDA Research Monograph 141. Baltimore, MD, 1994, pp 32-38.
76. Staley, J. K.; Hearn, W. L.; Ruttenber, A. J.; Wetli, C. V.; Mash, D. C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther., 1994, 271(3), 1678-1685.
77. Staley J, Wetli C, Ruttenber A, et al.: Altered dopaminergic synaptic markers in cocaine psychosis and sudden death. In: Harris LS: NIDA Research Monograph 153, 1995, 153, 491-504.
78. Seeman, P.; Van Tol, H. H. Dopamine receptor pharmacology. Trends Pharmacol. Sci., 1994, 15(7), 264-270.
79. Kosten, T. R.; Kleber, H. D. Rapid death during cocaine abuse: a variant of neuroleptic malignat syndrome? Am. J. Drug Alcohol Abuse, 1988, 14(3), 335-346.
80. Mirchandani, H. G.; Rorke, L. B.; Sekula-Perlman, A.; Hood, I. C. Cocaineinduced agitated delirium, forceful struggle, and minor head injury. A further definition of sudden death during restraint. Am. J. Forensic Med. Pathol., 1994, 15(2), 95-99.
81. Karch, S. B.; Green, G. S.; Young, S. Myocardial hypertrophy and coronary artery disease in male cocaine users. J. Forensic Sci., 1995, 40(4), 591-595.
82. Harris, D.; Batki, S. L. Stimulant psychosis: symptom profile and acute clinical course. Am. J. Addict, 2000, 9(1), 28-37.
83. Brady, K. T.; Lydiard, R. B.; Malcolm, R.; Ballenger, J. C. Cocaine-induced psychosis. J. Clin. Psychiatry., 1991, 52(12), 509-512.
84. Ellison, G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Brain Res. Rev., 1994, 19(2), 223-239.
85. McDowell, D. M.; Levin, F. R.; Seracini, A. M. Venlafaxine treatment of cocaine abusers with depressive disorders. Am. J. Drug Alcohol Abuse, 2000, 26(1), 25-31.
86. Roy, A. Characteristics of cocaine-dependent patients who attempt suicide. Am. J. Psychiatry, 2001, 158(8), 1215-1219.
87. Compton, W. M. 3rd; Cottler, L. B.; Ben Abdallah, A.; Phelps, D. L.; Spitznagel, E. L.; Horton, J. C. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am. J. Addict, 2000, 9(2), 113-125.
88. Weddington, W. W.; Brown, B. S.; Haertzen, C. A.; Cone, E. J.; Dax, E. M.; Herning, R. I.; Michaelson, B. S. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch. Gen. Psychiatry, 1990, 47(9), 861-868.
89. Kristensen, P.; Judge, M. E.; Thim, L.; Ribel, U.; Christjansen, K. N.; Clausen, J. T.; Jensen, P. B.; Madsen, O. D.; Vrang, N.; Larsen, P. J.; Hastrup, S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature, 1998, 393(6680), 72-76.
90. Turillazzi, E.; Riezzo, I. Drugs of abuse and pathology of the Heart. In: Pathology of the Heart and Sudden Death in Forensic Medicine; Fineschi, V.; Baroldi, G.; Silver, M. D., Eds.; CRC. Boca Raton, 2006; pp 341-359.
91. Maraj, S.; Figueredo, V. M.; Lynn Morris, D. Cocaine and the heart. Clin. Cardiol., 2010, 33(5), 264-269.
92. Phillips, K.; Luk, A.; Soor, G. S.; Abraham, J. R.; Leong, S.; Butany, J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am. J. Cardiovasc. Drugs., 2009, 9(3), 177-196.
93. Morcos, N. C.; Fairhust, A.; Henry, W. L. Direct myocardial effects of cocaine. Cardiovasc. Res., 1993, 27(2), 269-273.
94. Vitullo, J. C.; Karam, R.; Mekhail, N.; Wicker, P.; Engelmann, G. L.; Khairallah, P. A. Cocaine-induced small vessel spasm in isolated rat hearts. Am. J. Pathol., 1989, 135(1), 85-91.
95. Shannon, R. P.; Mathier, M. A.; Shen, Y. T. Coronary vascular responses to short-term cocaine administration in conscious baboons compaired with dogs. J. Am. Coll. Cardiol., 2000, 35(5), 1347-1354.
96. Fraker, T. D.; Temesy-Armos, P. N.; Brewster, P. S.; Wilkerson, R. D. Mechanism of cocaine-induced myocardial depression in dogs. Circulation., 1990, 81(3), 1012-1016.
97. Steinhauer, J. R.; Caulfield, J. B. Spontaneous coronary artery dissection associated with cocaine use: a case report and brief review. Cardiovasc. Pathol., 2001, 10(3), 141-145.
98. Hayes, S. N.; Moyer, T. P.; Morley, D.; Bove, A. A. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog. Am. Heart J., 1991, 121(6), 1639-1648.
99. Fan, L.; Sawbridge, D.; George, V.; Teng, L.; Bailey, A.; Kitchen, I.; Li, J. M. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase. J. Pharmacol. Exp. Ther., 2009, 328(1), 99-106.
100. Vasica, G.; Tennant, C. C. Cocaine use and cardiovascular complications. Med. J. Aust., 2002, 177(5), 260-262.
101. Darke, S.; Kaye, S.; Duflou, J. Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes. Addiction., 2006, 101(12), 1771-1777.
102. Afonso, L.; Mohammad, T.; Thatai, D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am. J. Cardiol., 2007, 100(6), 1040-1043.
103. Isabelle, M.; Vergeade, A.; Moritz, F.; Dautréaux, B.; Henry, J. P.; Lallemand, F.; Richard, V.; Mulder, P.; Thuillez, P.; Monteil, C. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J. M. Cell. Cardiol., 2007, 42(2), 326-332.
104. Vongpatanasin, W.; Mansour, Y.; Chavoshan, B.; Arbique, D.; Victor, R. G. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation., 1999, 100(5), 497-502.
105. Egashira, K.; Morgan, K. G.; Morgan, J. P. Effects of cocaine on excitationcontraction coupling of aortic smooth muscle from the ferret. J. Clin. Invest., 1991, 87(4), 1322-1328.
106. Lange, R. A.; Cigarroa, R. G.; Yancy, C. W. Jr.; Willard, J. E.; Popma, J. J.; Sills, M. N.; McBride, W.; Kim, A. S.; Hillis, L. D. Cocaine-induced coronary artery vasoconstriction. N. Engl. J. Med., 1989, 321(23), 1557-1562.
107. Fineschi, V.; Baroldi, G.; Centini, F.; Cerretani, D.; Fiaschi, A. I.; Micheli, L.; Parolini, M.; Turillazzi, E.; Giorgi, G. Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model. Int. J. Legal. Med., 2001, 114(6), 323-330.
108. Devi, B. G.; Chan, A. W. Effect of cocaine on cardiac biochemical functions. J. Cardiovasc. Pharmacol., 1999, 33(1), 1-6.
109. Behonick, G. S.; Novak, M. J.; Nealley, E. W.; Baskin, S. I. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J. Appl. Toxicol., 2001, 21(Suppl 1), S15-22.
110. Amin, J. K.; Xiao, L.; Pimental, D. R.; Pagano, P. J.; Singh, K.; Sawyer, D. B.; Colucci, W. S. Reactive oxygen species mediate alpha-adrenergic receptorstimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol., 2001, 33(1), 131-139.
111. Brandes, R. P.; Kreuzer, J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc. Res., 2005, 65(1), 16-27.
112. Landmesser, U.; Dikalov, S.; Price, S. R.; McCann, L.; Fukai, T.; Holland, S. M.; Micth, W. E.; Harrison, D. G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest., 2003, 111(8), 1201-1209.
113. Moritz, F.; Monteil, C.; Isabelle, M.; Bauer, F.; Renet, S.; Mulder, P.; Richard, V.; Thuillez, C. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc. Res., 2003, 59(4), 834-843.
114. Boess, F.; Ndikum-Moffor, F. M.; Boelsterli, U. A.; Roberts, S. M. Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochem. Pharmacol., 2000, 60(5), 615-623.
115. Kovacic, P. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med. Hypotheses, 2005, 64(2), 350-356.
116. Pacifici, R.; Fiaschi, A. I.; Micheli, L.; Centini, F.; Giorgi, G.; Zuccaro, P.; Pichini, S.; Di Carlo, S.; Bacosi, A.; Cerretani, D. Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat. Int. Immunopharmacol., 2003, 3(4), 581-592.
117. Li, J. M.; Gall, N. P.; Grieve, D. J.; Chen, M.; Shah, A. M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension, 2002, 40(4), 477-484.
118. Przywara, D. A.; Dambach, G. E. Direct actions of cocaine on cardiac cellular electrical activity. Circ. Res., 1989, 65(1), 185-192.
119. Schwartz, B. G.; Rezkalla, S.; Kloner, R. A. Cardiovascular Effects of Cocaine. Circulation, 2010, 122(24), 2558-2569.
120. Ghuran, A.; Nolan, J. Recreational drug misuse: issues for the cardiologist. Heart, 2000, 83(6), 627-633.
121. Wang, J. F.; Zhang, J.; Min, J. Y.; Sullivan, M. F.; Crumpacker, C. S.; Abelmann, W. H.; Morgan, J. P. Cocaine enhances myocarditis induced by encephalomyocarditis virus in murine model. Am. J. Physiol. Heart Circ. Physiol., 2002, 282(3), H956-963.
122. Frishman, W. H.; Del Vecchio, A.; Sanal, S.; Ismail, A. Cardiovascular manifestations of substance abuse part 1: cocaine. Heart Dis., 2003, 5(3), 187-201.
123. Jentzen, J. M. Cocaine-induced myocarditis. Am. Heart J., 1989, 117(6), 1398-1399.
124. Virmani, R.; Robinowitz, M.; Smialek, J. E.; Smyth, D. F. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am. Heart J., 1988, 115(5), 1068-1076.
125. Coleman, D. L.; Ross, T. F.; Naughton, J. L. Myocardial ischemia and infarction related to recreational cocaine use. West J. Med., 1982, 136(5), 444-446.
126. Erwin, M. B.; Hoyle, J. R.; Smith, C. H.; Deliargyris, E. N. Cocaine and accelerated atherosclerosis: insights from intravascular ultrasound. Int. J. Cardiol., 2004, 93(2-3), 301-303.
127. Mittleman, M. A.; Mintzer, D.; Maclure, M.; Tofler, G. H.; Sherwood, J. B.; Muller, J. E. Triggering of myocardial infarction by cocaine. Circulation, 1999, 99(21), 2737-2741.
128. Hollander, J. E.; Hoffman, R. S.; Burstein, J. L.; Shih, R. D.; Thode, H. C. Jr. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch. Intern. Med., 1995, 155(10), 1081-1086.
129. Kloner, R. A.; Hale, S.; Alker, K.; Rezkall, S. The effects of acute and chronic cocaine use on the heart. Circulation, 1992, 85(2), 407-419.
130. Hale, S. L.; Alker, K. J.; Rezkalla, S.; Figures, G.; Kloner, R. A. Adverse effects of cocaine on cardiovascular dynamics, myocardial blood flow, and coronary artery diameter in an experimental model. Am. Heart J., 1989, 118(5 Pt 1), 927-933.
131. Kuhn, F. E.; Johnson, M. N.; Gillis, R. A.; Visner, M. S.; Schaer, G. L. Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs. J. Am. Coll. Cardiol., 1990, 16(6), 1481-1491.
132. Kuhn, F. E.; Gillis, R. A.; Virmani, R.; Visner, M. S.; Schaer, G. L. Cocaine produces coronary artery vasoconstriction independent of an intact endothelium. Chest, 1992, 102(2), 581-585.
133. Zimring, H. J.; Fitzgerald, R. L.; Engler, R. L.; Ito, B. R. Intracoronary versus intravenous effects of cocaine on coronary flow and ventricular function. Circulation, 1994, 89(4), 1819-1828.
134. Shannon, R. P.; Manders, W. T.; Shen, Y. T. Role of blood doping in the coronary vasoconstrictor response to cocaine. Circulation, 1995, 92(1), 96-105.
135. Egashira, K.; Pipers, F. S.; Morgan, J. P. Effects of cocaine on epicardial coronary artery reactivity in miniature swine after endothelial injury and high cholesterol feeding. In vivo and in vitro analysis. J. Clin. Invest., 1991, 88(4), 1307-1314.
136. Awtry, E. H.; Philippides, G. J. Alcoholic and cocaine-associated cardiomyopathies. Prog. Cardiovasc. Dis., 2010, 52(4), 289-299.
137. Benzaquen, B. S.; Cohen, V.; Eisenberg, M. J. Effects of cocaine on the coronary arteries. Am. Heart J., 2001, 142(3), 402-410.
138. Flores, E. D.; Lange, R. A.; Cigarroa, R. G.; Hillis, L. D. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J. Am. Col.l Cardiol., 1990, 16(1), 74-79.
139. Moliterno, D. J.; Lange, R. A.; Gerard, R. D.; Willard, J. E.; Lackner, C.; Hillis, L. D. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am. J. Med., 1994, 96(6), 492-496.
140. Brogan, W. C. 3rd; Lange, R. A.; Glamann, D. B.; Hillis, L. D. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann. Intern. Med., 1992, 116(7), 556-561.
141. Togna, G.; Tempesta, E.; Togna, A. R.; Dolci, N.; Cebo, B.; Caprino, L. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis, 1985, 15(2), 100-107.
142. Kugelmass, A. D.; Shannon, R. P.; Yeo, E. L.; Ware, J. A. Intravenous cocaine induces platelet activation in the conscious dog. Circulation, 1995, 91(5), 1336-1340.
143. Wilbert-Lampen, U.; Seliger, C.; Zilker, T.; Arendt, R. M. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation, 1998, 98(5), 385-390.
144. Stenberg, R. G.; Winniford, M. D.; Hillis, L. D.; Dowling, G. P.; Buja, L. M. Simultaneous acute thrombosis of two major coronary arteries following intravenous cocaine use. Arch. Pathol. Lab. Med., 1989, 113(5), 521-524.
145. Delaney, K.; Hoffman, R. S. Pulmonary infarction associated with crack cocaine use in a previously healthy 23-year-old woman. Am. J. Med., 1991, 91(1), 92-94.
146. Zamora-Quezada, J. C.; Dinerman, H.; Stadecker, M. J.; Kelly, J. J. Muscle and skin infarction after free-basing cocaine (crack). Ann. Intern. Med., 1988, 108(4), 564-566.
147. Sharff, J. A. Renal infarction associated with intravenous cocaine use. Ann. Emerg. Med., 1984, 13(12), 1145-1147.
148. Dressler, F. A.; Malekzadeh, S.; Roberts, W. C. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am. J. Cardiol., 1990, 65(5), 303-308.
149. Om, A.; Warner, M.; Sabri, N.; Cecich, L.; Vetrovec, G. Frequency of coronary artery disease and left ventricle dysfunction in cocaine users. Am. J. Cardiol., 1992, 69(19), 1549-1552.
150. Kolodgie, F. D.; Virmani, R.; Cornhill, J. F.; Herderick, E. E.; Smialek, J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J. Am. Coll. Cardiol., 1991, 17(7), 1553-1560.
151. Wilson, L. D. Rapid progression of coronary artery disease in the setting of chronic cocaine abuse. J. Emerg. Med., 1998, 16(4), 631-634.
152. Roberts, W. C. Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaques in the major epicardial coronary arteries at necropsy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and unstable angina pectoris. Am. J. Cardiol., 1989, 64(5), 324-328.
153. Khan, I. A. Long QT syndrome: diagnosis and management. Am. Heart J., 2002, 143(1), 7-14.
154. Bauman, J. L.; Grawe, J. J.; Winecoff, A. P.; Hariman, R. J. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J. Clin. Pharmacol., 1994, 34(9), 902-911.
155. Bauman, J. L.; Di Domenico, R. J. Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death. J. Cardiovasc. Pharmacol. Ther., 2002, 7(3), 195-202.
156. Goldfrank, L. R.; Hoffman, R. S. The cardiovascular effects of cocaine. Ann. Emerg. Med., 1991, 20(2), 165-175.
157. Beckman, K. J.; Parker, R. B.; Hariman, R. J.; Gallastegui, J. L.; Javaid, J. I.; Bauman, J. L. Hemodynamic and electrophysiological actions Voltage-gated ion channels and cocaine-induced arrhythmia of cocaine. Effects of sodium bicarbonate as an antidote in dogs. Circulation, 1991, 83(5), 1799-1807.
158. Clarkson, C. W.; Xu, Y. Q.; Chang, C.; Follmer, C. H. Analysis of the ionic basis for cocaine's biphasic effect on action potential duration in guinea-pig ventricular myocytes. J. Mol. Cell. Cardiol., 1996, 28(4), 667-678.
159. Crumb, W. J.; Clarkson, C. W. Characterization of cocaine-induced block of cardiac sodium channels. Biophys. J., 1990, 57(3), 589-599.
160. Kimura, S.; Bassett, A. L.; Xi, H.; Myerburg, R. J. Early afterdepolarizations and triggered activity induced by cocaine. A possible mechanism of cocaine arrhythmogenesis. Circulation, 1992, 85(6), 2227-2235.
161. Mittleman, R. E.; Wetli, C. V. Death caused by recreational cocaine use. An update. J. A. M. A., 1984, 252(14), 1889-1893.
162. Weidmann, S. Effect of calcium ions and local anesthetics on electrical properties of Purkinje fibres. J. Physiol., 1955, 129(3), 568-582.
163. Perron, A. D.; Gibbs, M. Thoracic aortic dissection secondary to crack cocaine ingestion. Am. J. Emerg. Med., 1997, 15(5), 507-509.
164. Cohle, S. D.; Lie, J. T. Dissection of the aorta and coronary arteries associated with acute cocaine intoxication. Arch. Pathol. Lab. Med., 1992, 116(11), 1239-1241.
165. Gadaleta, D.; Hall, M. H.; Nelson, R. L. Cocaine-induced acute aortic dissection. Chest, 1989, 96(5), 1203-1205.
166. Barth, C. W. 3rd, Bray, M.; Roberts, W. C. Rupture of the ascending aorta during cocaine intoxication. Am. J. Cardiol., 1986, 57(6), 496.
167. Rashid, J.; Eisenberg, M. J.; Topol, E. J. Cocaine-induced aortic dissection. Am. Heart J., 1996, 132(6), 1301-1304.
168. Famularo, G.; Polchi, S.; Di Bona, G.; Manzara, C. Acute aortic dissection after cocaine and sildenafil abuse. J. Emerg. Med., 2001, 21(1), 78-79.
169. Hsue, P. Y.; Salinas, C. L.; Bolger, A. F.; Benowitz, N. L.; Waters, D. D. Acute aortic dissection related to crack cocaine. Circulation, 2002, 105(13), 1592-1595.
170. Eagle, K. A.; Isselbacher, E. M.; De Sanctis, R. W.; International Registry for Aortic Dissection (IRAD) Investigators. Cocaine-related aortic dissection in perspective. Circulation, 2002, 105(13), 1529-1530.
171. Eisenberg, M. J.; Yakel, D. L.; Mendelson, J.; Redberg, R. F.; Jones, R. T.; Foster, E. Immediate effects of intravenous cocaine on the thoracic aorta and coronary arteries. A transesophageal echocardiographic study. Chest, 1996, 110(1), 147-154.
172. Pretty, H. C. Dissecting aneurysm of coronary artery in a woman aged 42: rupture. Br. Med. J., 1931, 1, 667.
173. Jaffe, B. D.; Broderick, T. M.; Leier, C. V. Cocaine-induced coronary-artery dissection. N. Engl. J. Med., 1994, 330(7), 510-511.
174. Su, J.; Li, J.; Li, W.; Altura, B.; Altura B. Cocaine induces apoptosis in primary cultured rat aortic vascular smooth muscle cells: possible relationship to aortic dissection, atherosclerosis, and hypertension. Int. J. Toxicol., 2004, 23(4), 233-237.
175. Pitts, W. R.; Vongpatanasin, W.; Cigarroa, J. E.; Hillis, L. D.; Lange, R. A. Effects of intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans. Circulation, 1998, 97(13), 1270-1273.
176. Zhang, A.; Cheng, T. P.; Altura, B. T.; Altura, B. M. Acute cocaine
177. Eskander, K. E.; Brass, N. S.; Gelfand, E. T. Cocaine abuse and coronary artery dissection. Ann. Thorac. Surg., 2001, 71(1), 340-341.
178. Neri, E.; Toscano, T.; Massetti, M.; Capannini, G.; Frati, G.; Sassi, C. Cocaine-induced intramural hematoma of the ascending aorta. Tex. Heart Inst. J., 2001, 28(3), 218-219.
179. Moritz, F.; Monteil, C.; Isabelle, M.; Mulder, P.; Henry, J. P.; Derumeaux, G.; Richard, V.; Muller, J. M.; Thuillez, C. Selenium diet-supplementation improves cocaine-induced myocardial oxidative stress and prevents cardiac dysfunction in rats. Fundam. Clin. Pharmacol., 2004, 18(4), 431-436.
180. Baroldi, G.; Mittleman, R. E.; Parolini, M.; Silver, M. D.; Fineschi, V. Myocardial contraction bands. Definition, quantification and significance in forensic pathology. Int. J. Legal Med., 2001, 115(3), 142-151.
181. Milroy, C. M.; Parai, J. L. The histopathology of drugs of abuse. Histopathology, 2011, 59(4), 579-593.
182. Turillazzi, E.; Di Giammarco, G.; Neri, M.; Bello, S.; Riezzo, I.; Fineschi, V. Coronary ostia obstruction after replacement of aortic valve prosthesis. Diagn. Pathol.; 2011, 2(6), 72.
183. Fineschi, V.; Silver, M. D.; Karch, S. B.; Parolini, m.; Turillazzi, E.; Pomara, C.; Baroldi, G. Myocardial disarray: an architectural disorganization linked with adrenergic stress? Int. J. Cardiol., 2005, 99(2), 277-282.
184. Ferrans, V. J.; Morrow, A. G.; Roberts, W. C. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation, 1972, 45(4), 769-792.
185. Witzke, D. J.; Kaye, M. P. Myocardial ultrastructural changes induced by administration of nerve growth factors. Surg. Forum, 1976, 27(62), 295-297.
186. Hawkey, C. M.; Olsen, E. G.; Symons C. Production of cardiac muscle abnormalities in offspring of rats receiving triiodothyroacetic acid (triac) and the effect of betadrenergic blockade. Cardiovasc. Res., 1981, 15(4), 196-205.
187. Laks, M. M.; Morady, F.; Swan, H. J. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest, 1973, 64(1), 75-78.
188. Blautass, A. H. Production of ventricular hypertrophy simulating idiopathic hypertrophic subaortic stenosis (IHSS) by subhypertensive infusion of norepinephrine (NE) in the conscious dog (abstract). Clin. Res., 1975, 23, 77-83.
189. Bisognano, J. D.; Weinberger, H. D.; Bohlmeyer, T. J.; Pende, A.; Raynolds, M. V.; Sastravaha, A.; Roden, R.; Asano, K.; Blaxall, B. C.; Wu, S. C.; Communal, C.; Singh, K.; Colucci, W.; Bristow, M. R.; Port, D. J. Myocardialdirected overexpression of the human beta (1)-adrenergic receptor in transgenic mice. J. Mol. Cell. Cardiol., 2000, 32(5), 817-830.
190. Laposata, E. A.; Mayo, G. L. A review of pulmonary pathology and mechanisms associated with inhalation of freebase cocaine ("crack"). Am. J. Forensic Med. Pathol., 1993, 14(1), 1-9.
191. Itkonen, J.; Schnoll, S.; Glassroth, J. Pulmonary dysfunction in "freebase" cocaine users. Arch. Intern. Med., 1984, 144(11), 2195-2197.
192. Tashkin, D. P.; Khalsa, M. E.; Gorelick, D.; Chang, P.; Simmons, M. S.; Coulson, A. H.; Gong, H. Jr. Pulmonary status of habitual cocaine smokers. Am. Rev. Respir. Dis., 1992, 145(1), 92-100.
193. Baldwin, G. C.; Choi, R.; Roth, m.d.; Shay, A. H.; Kleerup, E. C.; Simmons, M. S.; Tashkin, D. P. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal ("crack") cocaine. Chest, 2002, 121(4), 1231-1238.
194. Terra Filho, M.; Yen, C. C.; Santos, Ude P.; Muñoz, D. R. Pulmonary alteration in cocaine users. Sao Paulo Med. J., 2004, 122(1), 26-31.
195. Greenebaum, E.; Copeland, A.; Grewal, R. Blackened bronchoalveolar lavage fluid in crack smokers. A preliminary study. Am. J. Clin. Pathol., 1993, 100(5), 481-487.
196. Restrepo, C. S.; Carrillo, J. A.; Martinez, S.; Ojeda, P.; Rivera, A. L.; Hatta, A. Pulmonary Complications from Cocaine and Cocaine-based Substances: Imaging Manifestations. Radiographics, 2007, 27(4), 941.
197. Forrester, J. M.; Steele, A. W.; Waldron, J. A.; Parsons, P. E. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am. Rev. Respir. Dis., 1990, 142(2), 462-467.
198. Kissner, D. G.; Lawrence, W. D.; Selis, J. E.; Flint, A. Crack lung: pulmonary disease caused by cocaine abuse. Am. Rev. Respir. Dis., 1987, 136(5), 1250-1252.
199. Murray, R.; Smialek, J.; Golle, M.; Albin, R. Pulmonary vascular abnormalities in cocaine users. Am. Rev. Respir. Dis., 1988, 137(Suppl 4), 459.
200. Suhl, J.; Gorelick, D. A. Pulmonary function in male freebase cocaine smokers [abstr]. Am. Re v. Respir. Dis., 1988, 137, A488.
201. Patel, R. C.; Dutta, D.; Schonfeld, S. A. Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann. Intern. Med., 1987, 107(2), 186-187.
202. Shesser, R.; Davis, C.; Edelstein, S. Pneumomediastinum and pneumothorax after inhaling alkaloid cocaine. Ann. Emerg. Med., 1982, 10(4), 213-215.
203. Morris, J. B.; Shock, J. M. Pneumomediastinum in a young male cocaine user. Ann. Emerg. Med., 1985, 14(2), 194-196.
204. Maklin, K. Malignant interstitial enphysema of the lungs and meiastinum as an important occult complication in many respiratory diseas and other complication; Macklin, Medicine (Baltimore), 1994, 23, pp 281-358.
205. Seaman, M. E. Barotrauma related to inhalation drug abuse. J. Emerg. Med., 1990, 8(2), 141-149.
206. Chan, L.; Pham, H.; Reece, E. A. Pneumothorax in pregnancy associated with cocaine use. Am. J. Perinatol., 1997, 14(7), 385-388.
207. Maeder, M.; Ullmer, E. Pneumomediastinum and bilateral pneumothorax as a complication of cocaine smoking. Respiration, 2003, 70(4), 407.
208. Uva, J. L. Spontaneous pneumothoraces, pneumomediastinum and pneumoperitoneum: consequences of smoking crack cocaine. Pediatr. Emerg. Care, 1997, 13(1), 24-26.
209. McCarroll, K. A.; Roszler, M. H. Lung disorders due to drug abuse. J. Thorac. Imaging, 1991, 6(1), 30-35.
210. Cucco, R. A.; Yoo, O. H.; Cregler, L.; Chang, J. C. Nonfatal pulmonary edema after "freebase" cocaine smoking. Am. Rev. Respir. Dis., 1987, 136(1), 179-181.
211. Perreault, C. L.; Hague, N. L.; Morgan, K. G.; Allen, P. D.; Morgan, J. P. Negative inotropic and relaxant effects of cocaine on myopathic human ventricular mycordium and epicardial coronary arteries in vitro. Cardiovasc. Res., 1993, 27(2), 262-268.
212. Raijemakers, P. G.; Groeneveld, A. B.; de Groot, M. C.; Teule, G. J.; Thijs, L. G. Delayed resolution of pulmonary oedema after cocaine/heroin abuse. Thorax, 1994, 49(10), 1038-1040.
213. Goldstein, D. S.; Karpel, J. P.; Appel, D.; Williams, M. H. Jr. Bullous pulmonary damage in users of intravenous drugs. Chest, 1986, 89(2), 266-269.
214. O'Donnell, A. E.; Pappas, L. S. Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest, 1988, 94(2), 251-253.
215. van der Klooster, J. M.; Grootendorst, A. F. Severe bullous emphysema associated with cocaine smoking. Thorax, 2001, 56(12), 982-983.
216. Rubin, R. B.; Neugarten, J. Cocaine-associated asthma. Am. J. Med., 1990, 88(4), 438-439.
217. Tashkin, D. P.; Kleerup, E. C.; Koyal, S. N.; Marques, J. A.; Goldaman, M. D. Acute effects of inhaled and i.v. cocaine on airway dynamics. Chest, 1996, 110(4), 904-910.
218. Bailey, M. E.; Fraire, A. E.; Greenberg, S. D.; Barnard, J.; Cagle, P. T. Pulmonary histopathology in cocaine abusers. Hum. Pathol., 1994, 25(2), 203-207.
219. Cooper, C. B.; Bai, T. R.; Heyderman, E.; Corrin, B. Cellulose granuloma in the lungs of a cocaine sniffer. Br. Med. J. (Clin. Res. Ed.), 1983, 286(6383), 2021-2022.
220. Janjua, T. M.; Bohan, A. E.; Wesselius, L. J. Increased lower respiratory tract iron concentrations in alkaloidal ("crack") cocaine users. Chest, 2001, 119(2), 422-427.
221. Fligiel, S. E.; Roth, M. D.; Kleerup, E. C.; Barsky, S. H.; Simmons, M. S.; Tashkin, D. P. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest, 1997, 112(2), 319-326.
222. Brody, S. L.; Slovis, C. M.; Wrenn, K. D. Cocaine-related medical problems: consecutive series of 233 patients. Am. J. Med., 1990, 88(4), 325-331.
223. Chauhan, S. S.; Krishnan, J.; Heffner, D. K. Solitary fibrous tumor of nasal cavity in patient with long-standing history of cocaine inhalation. Arch. Pathol. Lab. Med., 2004, 128(1), 1-4.
224. Barroso-Moguel, R.; Villeda-Hernàndez, J.; Mendez-Armenta, M.; Santamarìa, A.; Galvàn-Arzate, S. Alveolar lesions induced by systemic administration of cocaine to rats. Toxicol. Lett., 1999, 110(1-2), 113-118.
225. Wetli, C. V. Investigation of drug-related deaths. An overview. Am. J. Forensic Med. Pathol., 1984, 5(2), 111-120.
226. Mittleman, R. E.; Wetli, C. V. Cocaine and sudden "natural" death. J. Forensic Sci., 1987, 32(1), 11-19.
227. Escobedo, L. G.; Ruttenber, A. J.; Agocs, M. M.; Anda, R. F.; Wetli, C. V. Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida. Arch. Pathol. Lab. Med., 1991, 115(9), 900-905.
228. Mittleman, R. E.; Wetli, C. V. The pathology of cocaine abuse. Adv. Pathol. Lab. Med., 1991, 4, 37-73.
229. Karch, S. B.; Billingham, M. E. The pathology and etiology of cocaineinduced heart disease. Arch. Pathol. Lab. Med., 1988, 112(3), 225-230.
230. Murray, R. J.; Smialek, J. E.; Golle, M.; Albin, R. J. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest, 1989, 96(5), 1050-1053.
231. Tazelaar, H. D.; Karch, S. B.; Stephens, B. G., Billingham, M. E. Cocaine and the heart. Hum. Pathol., 1987, 18(2), 195-199.
232. Fineschi V, Gabrielli M, Masti A, Salvinelli R. Rilievi morfologici polmonari nella overdose da eroina e da cocaina. Medicina Legale-Quaderni Camerati. Anno XV, n. 2-1993.
233. Rofael, H. Z. Effect of ketamine pretreatment on cocaine-mediated hepatotoxicity in rats. Toxicol. Lett., 2004, 152(3), 213-222.
234. Diez-Fernandez, C.; Zaragoza, A.; Alvarez, A. M.; Cascales, M. Cocaine cytotoxicity in hepatocyte cultures from phenobarbital-induced rats: involvement of reactive oxygen species and expression of antioxidant defense systems. Biochem. Pharmacol., 1999, 58(5), 797-805.
235. Silva, M. O.; Roth, D.; Reddy, K. R.; Fernandez, J. A.; Albores-Saavedra, J.; Schiff, E. R. Hepatic dysfunction accompanying acute cocaine intoxication. J. Hepatol., 1991, 12(3), 312-315.
236. Radin, D. R. Cocaine-induced hepatic necrosis: CT demonstration. J. Comput. Assist. Tomogr., 1992, 16(1), 155-156.
237. Perino, L. E.; Warren, G. H.; Levine, J. S. Cocaine-induced hepatotoxicity in humans. Gastroenterology, 1987, 93, 176-180.
238. Wanless, I. R.; Dore, S.; Gopinath, N.; Tan, J.; Caeron, R.; Heathcote, E. J.; Blendis, L. M.; Levy, G. Histopathology of cocaine hepatotoxicity. Gastroenterology, 1990, 98, 487-501.
239. Kanel, G. C.; Cassidy, W.; Schuster, L.; Reynolds, T. B. Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models. Hepatology, 1990, 11, 646-651.
240. Ndikum-Moffor, F. M.; Roberts, S. M. Cocaine-protein targets in mouse liver. Biochem. Pharmacol., 2003, 66(1), 105-113.
241. Shuster, L.; Quimby, F.; Bates, A.; Thompson, M. L. Liver damage from cocaine in mice. Life Sci., 1977, 20(6), 1035-1041.
242. Evans, M. A.; Harbison, R. D. Cocaine-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol., 1978, 45(3), 739-754.
243. Labib, R.; Turkall, R.; Abdel-Rahman, M. S. Inhibition of cocaine oxidative metabolism attenuates endotoxin potentiation of cocaine mediated hepatotoxicity. Toxicology, 2002, 179(1-2), 9-19.
244. Roth, L.; Harbison, R. D.; James, R. C.; Tobin, T.; Roberts, S. M. Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology, 1992, 15, 934-940.
245. Gottfried, M. R.; Kloss, M. W.; Graham, D.; Rauckman, E. J.; Rosen, G. M. Ultrastructure of experimental cocaine hepatotoxicity. Hepatology, 1986, 6(2), 299-304.
246. Devi, B. G.; Chan, A. W. Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci., 1997, 60(11), 849-855.
247. Estroff, T. W.; Extein, I. L.; Malaspina, D.; Gold, M. S. Hepatitis in 101 consecutive suburban cocaine and opiate users. Int. J. Psychaitry Med., 1987, 16(3), 237-242.
248. Whitten, C. G.; Luke, B. A. Liver uptake of Tc-99m PYP. Clin. Nucl. Med., 1991, 16(7), 492-494.
249. Powers, J. F.; Alroy, J.; Shuster, L. Hepatic morphologic and biochemical changes induced by subacute cocaine administration in mice. Toxicol. Pathol., 1992, 20(1), 61-70.
250. Garhart, C. A.; Anwer, M. S.; Shuster, L. Cocaine-induced changes in perfusion pressure and bile flow in perfused rat livers. Biochem. Pharmacol., 1989, 38(13), 2139-2145.
251. Sarper, R.; Faraj, B. A.; Tarcan, Y. A.; Chandora, D. B.; Lenton, J. D. Assessment of splanchnic blood flow in alcohol and drug abuse using radionuclide angiography. J. Subst. Abuse, 1993, 5(3), 295-303.
252. Kloss, M. W.; Rosen, G. M.; Rauckman, E. J. Cocaine-mediated hepatotoxicity. A critical review. Biochem. Pharmacol., 1984, 33(2), 169-173.
253. Roberts, S. M.; James, R. C.; Harbison, R. D. Cocaine-induced hepatotoxicity. In: Cocaine. Pharmacology, Physiology, and Clinical Strategies; Lakoski, J. M.; Galloway, M. P.; White, F. J., Eds.; CRC Press. Boca Raton, 1992; pp. 15-33.
254. Selim, K.; Kaplowitz, N. Hepatotoxicity of psychotropic drugs. Hepatology, 1999, 29(5), 1347-1351.
255. Pellinen, P.; Stenback, F.; Kojo, A., Honkakoski, P.; Gelboin, H. V.; Pasanen, M. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Hepatology, 1996, 23(3), 515-523.
256. Cascales, M.; Alvarez, A.; Gascò, P.; Fernàndez- Simòn, L.; Sanz, N.; Boscà, L. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology, 1994, 20(4 Pt 1), 992-1001.
257. Sort, P.; Mas, A.; Salmeron, J. M.; Bruguera, M.; Rodés, J. Recurrent liver involvement in heatstroke. Liver, 1996, 16(5), 335-337.
258. Freeman, R. W.; Harbison, R. D. Hepatic periportal necrosis induced by chronic administration of cocaine. Biochem. Pharmacol., 1981, 45(7), 739-754.
259. Boelsterli, U. A.; Goldlin, C. Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch. Toxicol., 1991, 65(5), 352-360.
260. Pasanen, M.; Pellinen, P.; Stenback, F.; Juvonen, R. O.; Raunio, H.; Pelkonen, O. The role of CYP enzymes in cocaine-induced liver damage. Arch. Toxicol., 1995, 69(5), 287-290.
261. Bornheim, L. M. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity. Toxicol. Appl. Pharmacol., 1998, 150(1), 158-165.
262. Boelsterli, U.; Wolf, A.; Göldlin, C. Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology, 1993, 18(5), 1154-1161.
263. Powell, C. J.; Charles, S. J.; Mullervy, J. Cocaine hepatotoxicity: a study on the pathogenesis of periportal necrosis. Int. J. Exp. Pathol., 1994, 75(6), 415-424
264. Bouis, P.; Boelsterli, U. A. Modulation of cocaine metabolism in primary rat hepatocyte cultures: effect on irreversible binding and protein biosynthesis. Toxicol. Appl. Pharmacol., 1990, 104(3), 429-439.
265. Aoki, K.; Ohmori, M.; Takimoto, M.; Ota, H.; Yoshida, T. Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur. J. Pharmacol., 1997, 336(1), 43-49.
266. Devi, B. G.; Chan, A. W. K. Cocaine-induced peroxidative stress in rat liver: Antioxidant enzymes and mitochondria. J. Pharmacol. Exp. Ther., 1996, 279(1), 359-366.
267. Ndikum-Moffor, F. M.; Munson, J. W.; Bokinkere, N. K.; Brown, J. L.; Richards, N.; Roberts, S. M. Immunochemical detection of hepatic cocaineprotein adducts in mice. Chem. Res. Toxicol., 1998, 11(3), 185-192.
268. Masini, A.; Gallesi, D.; Giovannini, F.; Trenti, T.; Ceccarelli, D. Membrane potential of hepatic mitochondria after acute cocaine administration in rats-The role of mitochondrial reduced glutathione. Hepatology, 1997, 25(2), 385-390.
269. Boyer, C. S.; Shirey, J. J.; Petersen, D. R. Effects of cocaine and its oxidative N-demethylation products on isolated mouse liver mitochondrial respiration. Hepatology, 1988, 8, 1235.
270. Reid, M. J.; Bornheim, L. M. The effects of phencyclidine pretreatment on cocaine-mediated hepatotoxicity in mice. Toxicol. Appl. Pharmacol., 2001, 172(3), 194-202.
271. Evans, M. A. Role of protein binding in cocaine-induced hepatic necrosis. J. Pharmacol. Exp. Ther., 1983, 224(1), 73-79.
272. Lloyd, R. V.; Shuster, L.; Mason, R. P. Reexamination of the microsomal transformation of N-hydroxynorcocaine to norcocaine nitroxide. Mol. Pharmacol., 1993, 43(4), 645-648.
273. Michael, S. L.; Pumford, N. R.; Mayeux, P. R.; Niesman, M. R.; Hinson, J. A. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and species. Hepatology, 1999, 30(1), 186-195.
274. Zaragoza, A.; Dìez-Fernandez, C.; Alvarez, A.; Andrés, D.; Cascales, M. Effect of N-acetylcysteine and deferoxamine on endogenous antioxidant defense system gene expression in a rat hepatocyte model of cocaine cytotoxicity. Biochim. Biophys. Acta, 2000, 1496(2-3), 183-195.
275. Thompson, M. L.; Shuster, L.; Shaw, K. Cocaine induced hepatic necrosis in mice-the role of cocaine metabolism. Biochem. Pharmacol., 1979, 28(15), 2389-2395.
276. Rauckman, E. J.; Rosen, G. M.; Cavagnaro, J. Norcocaine nitroxide: a potential hepatotoxic metabolite of cocaine. Mol. Pharmacol., 1982, 211, 458-463.
277. Charkoudian, J. C.; Shuster, L. Electrochemistry of norcocaine nitroxide and related compounds: implications for cocaine hepatotoxicity. Biochem. Biophys. Res. Commun., 1985, 130(3), 1044-1051.
278. Göldlin, C.; Boelsterli, U. A. Dissociation of covalent protein adducts formation from oxidative injury in cultured hepatocytes exposed to cocaine. Xenobiotica, 1994, 24(3), 251-264.
279. Ponsoda, X.; Bort, R.; Jover, R.; Gómez-Lechón, M. J.; Castell, J. V. Increased toxicity of cocaine on human hepatocytes induced by ethanol: role of GSH. Biochem. Pharmacol., 1999, 58(10), 1579-1585.
280. Hayase, T.; Yamamoto, Y.; Yamamoto, K.; Abiru, H.; Nishitani, Y.; Fukui, Y. Relationship between cocaine-induced hepatotoxic neurobehavioral & biochemical changes in mice: the antidotal effects of buprenorphine. Life Sci., 2000, 67(1), 45-52.
281. Jones, E. A.; Weissenborn, K. Neurology and the liver. J. Neurol. Neurosurg. Psychiatry, 1997, 63(3), 279-293.
282. James, R. C.; Schiefer, M. A.; Roberts, S. M.; Harbison, R. D. Antagonism of cocaine-induced hepatotoxicity by the alpha adrenergic antagonists phentolamine and yohimbine. J. Pharmacol. Exp. Ther., 1987, 242(2), 726-732.
283. Roberts, S. M.; De Mott, R. P.; James, R. C. Adrenergic modulation of hepatotoxicity. Drug Metab. Rev., 1997, 29(1-2), 329-353.
284. Meehan, S. M.; Schechter, M. D. Premorbid behaviors produced by cocaine, ethanol and cocaethylene in the mouse. Gen. Pharmacol., 1995, 26(1), 99-106.
285. Jaffe, J. A.; Kimmel, P. L. Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review. Clin. J. Am. Soc. Nephrol., 2006, 1(4), 655-667.
286. Lombard, J.; Wong, B.; Young, J. H. Acute renal failure due to rhabdomyolysis associated with cocaine toxicity. West J. Med., 1988, 148(4), 466-468.
287. Menasche, P. I.; Gottlieb, J. E. Hyperthermia, rhabdomyolysis, and myoglobinuric renal failure after recreational use of cocaine. South Med. J., 1988, 81(3), 379-381.
288. Glauser, J.; Queen, J. R. An overview of non-cardiac cocaine toxicity. J. Emerg. Med., 2007, 32(2), 181-186.
289. Pogue, V. A.; Nurse, H. M. Cocaine-associated acute myoglobinuric renal failure. Am. J. Med., 1989, 86(2), 183-186.
290. Anand, V.; Siami, G.; Stone, W. J. Cocaine-associated rhabdomyolysis and acute renal failure. South Med. J., 1989, 82(1), 67-69.
291. Roth, D.; Alarcon, F. J.; Fernandez, J. A.; Preston, R. A.; Bourgoignie, J. J. Acute rhabdomyolysis associated with cocaine intoxication. N. Engl. J. Med., 1988, 319(11), 673-677.
292. Horst, E.; Bennett, R. L.; Barrett, O. Jr. Recurrent rhabdomyolysis in association with cocaine use. South Med. J., 1991, 84(2), 269-270.
293. Welch, R.; Todd, K.; Krause, G. Incidence of cocaine-associated rhabdomyolysis. Ann. Emerg. Med., 1991, 20(2), 154-157.
294. Singhal, P.; Harowitz, B.; Quinones, M. C.; Sommer, M.; Faulkner, M.; Grosser, M. Acute renal failure following cocaine abuse. Nephron., 1989, 52(1), 76-78.
295. Nolte, K. B. Rhabdomyolysis associated with cocaine abuse. Hum. Pathol., 1991, 22(11), 1141-1145.
296. Ruttenber, A. J.; McAnally, H. B.; Wetli, C. V. Cocaine-associated rhabdomyolysis and excited delirium: Different stages of the same syndrome. Am. J. Forensic Med. Pathol., 1999, 20(2), 120-127.
297. Singhal, P. C.; Rubin, R. B.; Peters, A.; Santiago, A.; Neugarten, J. Rhabdomyolysis and acute renal failure associated with cocaine abuse. J. Toxicol. Clin. Toxicol., 1990, 28(3), 321-330.
298. Candnapaphornchai, P.; Taher, S.; McDonald, F. D. Acute drug-associated rhabdomyolysis: An examination of its diverse renal manifestations and complications. Am. J. Med. Sci., 1980, 280(2), 66-72.
299. Veenstra, J.; Smit, W. M.; Krediet, R. T.; Arisz, L. Relationship between elevated creatinine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol. Dial. Transplant., 1994, 9(6), 637-641.
300. Fogo, A.; Superdock, K. R.; Atkinson, J. B. Severe arteriosclerosis in the kidney of a cocaine addict. Am. J. Kidney Dis., 1992, 20(5), 513-515.
301. Kock, K. F.; Simonsen, K. W. Renal myoglobin in drug addicts: occurrence and significance in a postmortem study. Forensic Sci. Int., 1994, 65(2), 113-119.
302. Kapasi, A. J.; Mattana, J.; Wagner, J. Morphine amplifies cocaineinduced renal cortical expression of tissue inhibitors of metalloproteinase (TIMP)-2 [abstract]. J. Am. Soc. Nephrol., 1997, 6, 528A.
303. Kolodgie, FD.; Wilson, P. S.; Cornhill, J. F.; Herderick, E. E.; Mergner, W. J.; Virmani R. Increased prevalence of aortic fatty streaks in cholesterol-fed rabbits administered intravenous cocaine: The role of vascular endothelium. Toxicol. Pathol., 1993, 21(5), 425-434.
304. Nzerue, C. M.; Hewan-Lowe, K.; Riley, L. J. Jr. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am. J. Kidney Dis., 2000, 35(5), 783-785.
305. Bemanian, S.; Motallebi, M.; Nosrati, S. M. Cocaine-induced renal infarction: report of a case and review of the literature. BMC Nephrology, 2005, 6-10.
306. Antonovych, T. T.; Sabnis, S. G.; Finkelstein, A.; Yadla, R. K. Unusual renal involvement in two cocaine addicts [abstract]. J. Am. Soc. Nephrol., 1990, 1, 326A.
307. Goodman, P. E.; Rennie, W. P. Renal infarction secondary to nasal insufflation of cocaine. Am. J. Emerg. Med., 1995, 13(4), 421-423.
308. Saleem, T. M.; Singh, M.; Murtaza, M.; Singh, A.; Kasubhai, M.; Gnanasekaran, I. Renal infarction: a rare complication of cocaine abuse. Am. J. Emerg. Med., 2001, 19(6), 528-529.
309. Edmondson, D. A.; Towne, J. B.; Foley, D. W.; Abu-Hajir, M.; Kochar, M. S. Cocaine-induced renal artery dissection and thrombosis leading to renal infarction. WMJ, 2004, 103(7), 66-69.
310. Mochizuki, Y.; Zhang, M.; Golestaneh, L.; Thananart, S.; Coco, M. Acute aortic thrombosis and renal infarction in acute cocaine intoxication: a case report and review of literature. Clin. Nephrol., 2003, 60(2), 130-133.
311. Lagner, R. O.; Bement, C. L.; Cohen, L.; Nielsen, S. W. Stimulation of atherogenesis by cocaine in cholesterol-fed rabbits [Abstract]. FASEB J., 1989, 3, 297A.
312. Tonga, G.; Tempesta, E.; Tonga, A. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis, 1989, 15(2), 100-107.
313. Kugelmass, A. D.; Oda, A.; Monahan, K.; Cabral, C.; Ware, J. A. Activation of human platelets by cocaine. Circulation, 1993, 88(3), 876-883.
314. Kramer, R. K.; Turner, R. C. Renal infarction associated with cocaine use and latent protein c deficiency. South Med. J., 1993, 86(12), 1436-1438.
315. Langner, R. O.; Bement, C. L. Cocaine-induced changes in the biochemistry and morphology of rabbit aorta. NIDA Res. Monogr., 1991, 108, 154-166.
316. Escobedo, L. G.; Ruttenberg, A. J.; Anda, R. F.; Sweeney, P. A.; Wetly, C. V. Coronary artery disease, left ventricular hypertrophy, and the risk of cocaine overdose death. Coronary Artery Disease, 1992, 3(9), 853-858.
317. Chiueh, C. C.; Kopin, I. J. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther., 1978, 205(1), 148-154.
318. Karch, S. B. Serum catecholamines in cocaine-intoxicated patients with cardiac symptoms. Ann. Emerg. Med., 1987, 16, 481-482.
319. Kohan, D. E. Endothelins in normal and diseased kidney. Am. J. Kidney Dis., 1997, 29(1), 2-26.
320. Cregler, L. L.; Mark, H. Medical complications of cocaine abuse. N. Engl. J. Med., 1986, 315(23), 1495-1500.
321. Resnick, R. B.; Kestenbaum, R. S.; Schwartz, L. R. Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes. Science, 1977, 195(4279), 696-698.
322. Kon, V.; Yoshioka, T.; Fogo, A.; Ichikawa, I. Glomerular actions of endothelin in vivo. J. Clin. Invest., 1989, 83(5), 1762-1767.
323. Hendricks-Munoz, K. D.; Gerrets, P. R.; Higgins, R. D.; Munoz, J. L.; Caines, V. V. Cocaine-stimulated endothelin-1 release is decreased by ACE inhibitors in cultured endothelial cells. Cardiovasc. Res., 1996, 31(1), 117-123.
324. Samuels, P.; Steinfeld, J. D.; Braitman, L. E., Rhoa, M. F.; Cines, D. B.; McCrae, K. R. Plasma concentration of endothelin-1 in women with cocaine-associated pregnancy complications. Am. J. Obstet. Gynecol., 1993, 168(2), 528-533.
325. Miyazaki, M.; Okunishi, H.; Nishimura, K.; Toda, N. Vascular angiotensinconverting enzyme activity in man and other species. Clin. Sci. (London), 1984, 66(1), 39-45.
326. Mo, W.; Singh, A. K.; Arruda, J. A.; Dunea, G. Role of nitric oxide in cocaine-induced acute hypertension. Am. J. Hypertens., 1998, 11(6 pt 1), 708-714.
327. Rogione, A. J.; Steg, P. G.; Gal, D.; Isner, J. M. Cocaine causes endotheliumindependent vasoconstriction of vascular smooth muscle [abstract]. Circulation, 1988, 78, 5436A.
328. Isner, J.; Chokshi, S. K. Cardiovascular complications of cocaine. Curr. Probl. Cardiol., 1991, 16(2), 89-123.
329. Palamara, A. T.; Di Francesco, P.; Ciriolo, M. R.; Buè, C.; Lafavia, E.; Rotilio, G.; Garaci, E. Cocaine increases Sendai virus replication in cultured epithelial cells: Critical role of intracellular redox status. Biochem. Biophys. Res. Commun., 1996, 228(2), 579-585.
330. Thakur, V.; Godley, C.; Weed, S.; Cook, M. E.; Hoffman, E. Case reports: cocaine-associated accelerated hypertension and renal failure. Am. J. Med. Sci., 1996, 312(6), 295-298.
331. Dunea, G.; Arruda, J. L.; Bakir, A. A.; Share, D. S.; Smith, E. C. Role of cocaine in end-stage renal disease in some hypertensive African-Americans. Am. J. Nephrol., 1995, 15(1), 5-9.
332. Bakir, A. A.; Bazilinski, N. G.; Rhee, H. L.; Ainis, H.; Dunea G. Focal segmental glomerulosclerosis. A common entity in nephrotic black adults. Arch. Intern. Med., 1989, 149(8), 1802-1804.
333. Korbet, S. M. Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol. Dial. Transplant., 1999, 14 Suppl 3, 68-73.
334. Kitiyakara, C.; Kopp, J. B.; Eggers, P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin. Nephrol., 2003, 23(2), 172-182.
335. Kitiyakara, C.; Eggers, P.; Kopp, J. B. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am. J. Kidney Dis., 2004, 44(5), 815-825.
336. Kopp, J. B.; Winkler, C. HIV-associated nephropathy in African Americans. Kidney Int. Suppl., 2003, (83), s43-s49.
337. Winn, M. P. Approach to the evaluation of heritable diseases and update on familial focal segmental glomerulosclerosis. Nephrol. Dial. Transplant., 2003, 18 [Suppl 6], 14-20.
338. Andreoli, S. P. Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children. Adv. Ren. Replace Ther., 2004, 11(1), 105-109.
339. Orloff, M. S.; Iyengar, S. K.; Winkler, C. A.; Goddard, K. A.; Dart, R. A.; Ahuja, T. S.; Mokrzycki, M.; Briggs, W. A.; Korbet, S. M.; Kimmel, P. L.; Simon, E. E.; Trachtman, H.; Vlahov, D.; Michel, D. M.; Berns, J. S.; Smith, M. C.; Schelling, J. R.; Sedor, J. R.; Kopp, J. B. Variants in the Wilms tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol. Genomics, 2005, 21(2), 212-221.
340. Tucker, J. K. Focal segmental glomerulosclerosis in African Americans. Am. J. Med. Sci., 2002, 323(2), 90-93.
341. Devarajan, P.; Spitzer, A. Towards a biological characterization of focal glomerulosclerosis. Am. J. Kidney Dis., 2002, 39(3), 625-636.
342. Schena, F. P. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients. J. Nephrol., 1999, 12 [Suppl 2], S125-S130.
343. Barroso-Moguel, R.; Mendez-Armenta, M.; Villeda-Hernandez, J.; Rios, C.; Galvan-Arzate, S. Experimental neuromyopathy induced by thallium in rats. J. Appl. Toxicol., 1996, 16(5), 385-389.
344. Barroso-Moguel, R.; Mendez-Armenta, M.; Villeda-Hernandez, J. Experimental nephropathy by chronic administration of cocaine in rats. Toxicology, 1995, 98(1-3), 41-46.
345. Peces, R.; Navascues, R. A.; Baltar, J.; Seco, M.; Alvarez, J. Antiglomerular basement membrane antibody-mediated glomerulonephritis after intranasal cocaine. Nephron., 1999, 81(4), 434-438.
346. Alvarez, D.; Nzerue, C. M.; Faruque, S.; Daniel, J. F.; Hewan-Lowe, K. Crack-cocaine induced acute interstitial nephritis. Nephrol. Dial. Transplant., 1999, 14(5), 1260-1262.
347. Fishel, R.; Hamamoto, G.; Barbul, A.; Jiji, V.; Efron, G. Cocaine colitis. Is this a new syndrome?. Dis. Colon Rectum, 1985, 28(4), 264-266.
348. Nalbandian, H.; Sheth, N.; Dietrich, R.; Georgiou, J. Intestinal ischemia caused by cocaine ingestion: report of two cases. Surgery, 1985, 97(3), 374-376.
349. Lee, H. S.; La Maute, H. R.; Pizzi, W. F.; Picard, D. L.; Luks, F. I. Acute gastroduodenal perforations associated with use of crack. Ann. Surg., 1990, 211(1), 15-17.
350. Sharma, R.; Organ, C. H. Jr.; Hirvela, E. R.; Henderson, V. J. Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation. Am. J. Surg., 1997, 174(6), 629-632.
351. Isner, J. M.; Chokshi, S. K. Cocaine and vasospasm. N. Engl. J. Med., 1989, 321(23), 1604-1606.
352. Collis, M. G; Alps, B. J. Vascular reactivity to noradrenaline, potassium chloride, and angiotensin-II in the rat perfused mesenteric vasculature preparation, during the development of renal hypertension. Cardiovasc. Res., 1975, 9(1), 118-126.
353. Creglar, L. L.; Mark, H. Medical complications of cocaine abuse. N. Engl. J. Med., 1986, 315(23), 1495-1500.
354. Szakacs, J. E.; Dimmette, R. M., Cowart, E. C. Jr. Pathologic implication of the catecholamines, epinephrine and norepinephrine. U. S. Armed Forces Med. J., 1959, 10, 908-925.
355. Miller, J. S.; Hendren, S. K.; Liscum, K. R. Giant gastric ulcer in a body packer. J. Trauma, 1998, 45(3), 617-619.
356. Abramson, D. L.; Gertler, J. P.; Lewis, T.; Kral, J. G. Crack-related perforated gastropyloric ulcer. J. Clin. Gastroenterol., 1991, 13(1), 17-19.
357. Brown, D. N.; Rosenholtz, M. J.; Marshall, J. B. Ischemic colitis related to cocaine abuse. Am. J. Gastroenterol., 1994, 89(9), 1558-1561.
358. Hebra, A.; Brown, M. F.; McGeehin, K.; O'Niell, J. A. Jr.; Ross, A. J. 3rd. Systemic and mesenteric vascular effects of platelet-activating factor and cocaine. In vivo effects on a neonatal swine model. Am. Surg., 1993, 59(1), 50-54.
359. Gourgoutis, G.; Das, G. Gastrointestinal manifestations of cocaine addiction. Int. J. Clin. Pharmacol. Ther., 1994, 32(3), 136-141.
360. Rezkalla, S. H.; Mazza, J. J.; Kloner, R. A.; Tillema, V.; Chang, S. H. The effect of cocaine on human platelets in healthy subjects. Am. J. Cardiol., 1993, 72(2), 243-246.
361. Eichorn, E. J.; Demian, S. E.; Alvarez, L. G.; Willard, J. E.; Molina, S.; Bartula, L. L.; Prince, M. D., Inman, L. R.; Grayburn, P. A.; Myers, S. I. Cocaineinduced alterations in prostaglandin production in rabbit aorta. J. Am. Coll. Cardiol., 1992, 19(3), 696-703.
362. Simpson, R. W.; Edwards, W. D. Pathogenesis of cocaine-induced ischemic heart disease. Autopsy findings in a 21-year-old man. Arch. Pathol. Lab. Med., 1986, 110(6), 479-484.
363. ® c Publications. New York, 1990; pp 550-559.
364. Wetli, C. V.; Rao, A.; Rao, V. J. Fatal heroin body packing. Am. J. Forensic Med. Pathol., 1997, 18(3), 312-318.
365. Heinemann, A.; Miyaishi, S.; Iwersen, S.; Schmoldt, A.; Püschel, K. Bodypacking as cause of unexpected sudden death. Forensic Sci. Int., 1998, 92(1), 1-10.
366. Gill, J. R.; Graham, S. M. Ten years of 'body packers' in New York City: 50 deaths. J. Forensic Sci., 2002, 47(4), 843-846.
367. Cawich, S. O.; Downes, R.; Martin, A. C.; Evans, N. R.; Mitchell, D. I.; Williams, E. Colonic perforation: a lethal consequence of cannabis body packing. J. Forensic Leg. Med., 2010, 17(5), 269-271.
368. Silvestre, F. J.; Perez-Herbera, A.; Puente-Sandoval, A.; Bagá, J. V. Hard palate perforation in cocaine abusers: a systematic review. Clin. Oral Invest., 2010, 14(6), 621-628.
369. Chow, J. M.; Robertson, A. L. Jr.; Stein, R. J. Vascular changes in the nasal submucosa of chronic cocaine addicts. Am. J. Forensic Med. Pathol., 1990, 11(2), 136-143.
370. Sittel, C.; Eckel, H. E. Nasal cocaine abuse presenting as a central facial destructive granuloma. Eur. Arch. Otorhinolaryngol., 1998, 255(9), 446-447.
371. Mayo-Smith, M. F.; Spinale, J. Thermal epiglottitis in adults: a new complication of illicit drug use. J. Emerg. Med., 1997, 15(4), 483-485.
372. Taylor, R. F.; Bernard, G. R. Airway complications from free-basing cocaine. Chest, 1989, 95(2), 476-477.
373. Daggett, R. B.; Haghighi, P.; Terkeltaub, R. A. Nasal cocaine abuse causing an aggressive midline intranasal and pharyngeal destructive process mimicking midline reticulosis and limited Wegener's granulomatosis. J. Rheumatol., 1990, 17(6), 838-840.
374. Rachapalli, S. M.; Kiely, P. D. Cocaine-induced midline destructive lesions mimicking ENT-limited Wegener's granulomatosis. Scand. J. Rheumatol., 2008, 37(6), 477-480.
375. Dick, A. D.; Prentice, M. G. Cocaine and acute porphyria. Lancet, 1987, 2(8568), 1150.
376. Schuster, D. S. Snorters' warts. Arch. Dermatol., 1987, 123(5), 571.
377. Kerr, H. D. Cocaine and scleroderma. South. Med. J., 1989, 82(10), 1275-1276.
378. Enrìquez, R.; Palacios, F. O.; Gonzàlez, C. M.; Amoros, F. A.; Cabezuelo, J. B.; Hernàndez, F. Skin vasculitis, hypokalemia and acute renal failure in rhabdomyolysis associated with cocaine. Nephron., 1991, 59(2), 336-337.
379. Chevalier, X.; Rostoker, G.; Larget-Piet, B.; Gherardi, R. Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin. Nephrol., 1995, 43(5), 348-349.
380. Orriols, R.; Muñoz, X.; Ferrer, J.; Huget, P.; Morell, F. Cocaine induced Churg-Strauss vasculites. Eur. Respir. J., 1996, 9(1), 175-177.
381. Weidman, A. I.; Fellner, M. J. Cutaneous manifestations of heroin and other addictive drugs. Study and analysis. N. Y. State J. Med., 1971, 71(22), 2643-2646.
382. Ebright, J. R.; Pieper, B. Skin and soft tissue infections in injection drug users. Infect. Dis. Clin. North. Am., 2002, 16(3), 697-712.
383. Del Giudice, P. Cutaneous complications of intravenous drug abuse. Br. J. Dermatol., 2004, 150(1), 1-10.
384. Summanen, P. H.; Talan, D. A.; Strong, C.; McTeague, M.; Bennion, R.; Thompson, J. E. Jr.; Väisänen, M. L.; Moran, G.; Winer, M.; Finegold, S. M. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin. Infect. Dis., 1995, 20(Suppl 2), 279-282.
385. Chen, J. L.; Fullerton, K. E.; Flynn, N. M. Necrotizing fasciitis associated with injection drug use. Clin. Infect. Dis., 2001, 33(1), 6-15.
386. Hsueh, P. R.; Hsiue, T. R.; Hsieh, W. C. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin. Infect. Dis., 1996, 22(5), 858-860.
387. Neugarten, J.; Gallo, G. R.; Buxbaum, J.; Katz, L. A.; Rubenstein, J.; Baldwin, D. S. Amyloidosis in subcutaneous heroin abusers ("skin poppers' amyloidosis"). Am. J. Med., 1986, 81(4), 635-640.
388. Tan, A. U. Jr.; Cohen, A. H.; Levine, B. S. Renal amyloidosis in a drug user. J. Am. Soc. Nephrol., 1995, 5(9), 1653-1658.
389. Hahn, H. H.; Schweid, A. I.; Beaty, H. N. Complications of injecting dissolved methylphenidate tablets. Arch. Intern. Med., 1969, 123(6), 656-659.
390. Feeney, C. M.; Briggs, S. Crack hands: a dermatologic effect of smoking crack cocaine. Cutis, 1992, 50(3), 193-194.
391. Sinha-Hikim, I.; Shen, R.; Nzenwa, I.; Gelfand, R.; Mahata, S. K.; Sinha-Hikim, A. P. Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis, 2011, 16(6), 563-573.
392. McCord, J.; Jneid, H.; Hollander, J. E.; de Lemos, J. A.; Cercek, B.; Hsue, P.; Gibler, W. B.; Ohman, E. M.; Drew, B.; Philippides, G.; Newby, L. K. Management of cocaine associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation, 2008, 117(14), 1897-1907.
393. Mone, S. M.; Gillman, M. W.; Miller, T. L.; Herman, E. H.; Lipshultz, S. E. Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. Pediatrics, 2004, 113(4 Suppl), 1058-1069.
394. Gaithner, K. Cocaine abuse in pregnancy: an evolution from placenta to pandemonium. South. Med. J., 2008, 101(8), 783-784.
395. Meyer, K. D.; Zhang, L. Short-and long-term adverse effects of cocaine abuse during pregnancy on the heart development. Ther. Adv. Cardiovasc. Dis., 2009, 3(1), 7-16.
396. Frassica, J. J.; Orav, E. J.; Walsh, E. P.; Lipshultz, S. E. Arrhythmias in children prenatally exposed to cocaine. Arch. Pediatr. Adolesc. Med., 1994, 148(11), 1163-1169.
397. Metha, S. K.; Finkelhor, R. S.; Anderson, R. L.; Harcar-Sevcik, R. A.; Wasser, T. E.; Bahler, R. C. Transient myocardial ischemia in infants prenatally exposed to cocaine. J. Pediatr., 1993, 122(6), 945-949.
398. Norris, M. K.; Hill, C. S. Assessing congenital heart defects in the cocaineexposed neonate. Dimens. Crit. Care Nurs., 1992, 11(1), 6-12.
399. Lipshultz, S. E.; Frassica, J. J.; Orav, E. J. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J. Pediatr., 1991, 118(1), 44-51.
400. Shaw, G. M.; Malcoe, L. H.; Lammer, E. J.; Swan, S. H. Maternal use of cocaine during pregnancy and congenital cardiac anomalies. J. Pediatr., 1991, 118(1), 167-168
401. Wiggins, R. C. Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation. Clin. Pharmacokinet., 1992, 22(2), 85-93.
402. van de Bor, M.; Walther, F. J.; Ebrahimi, M. Decreased cardiac output in infants of mothers who abused cocaine. Pediatrics, 1990, 85(1), 30-32.
403. Plessinger, M. A.; Woods, J. R. Jr. Cocaine in pregnancy. Recent data on maternal and fetal risks. Obstet. Gynecol. Clin. North Am., 1998, 25(1), 99-118.
404. Gintautiene, K.; Longmore, W.; Abadir, A. R.; Goy, G. R.; Berman, S.; Levendoglu, H.; Gintautas, J. Cocaine-induced deaths in pediatric population. Proc. West Pharmacol. Soc., 1990, 33, 247-248.
405. Schenker, S.; Yang, Y.; Johnson, R. F.; Downing, J. W. The transfer of cocaine and its metabolites across the term human placenta. Clin. Pharmacol. Ther., 1993, 53(3), 329-339.
406. Klein, J.; Greenwald, M.; Becker, L.; Koren, G. Fetal distribution of cocaine: case analysis. Pediatr. Pathol., 1992, 12(3), 462-468.
407. De Vane, C. L.; Simpkins, J. W.; Miller, R. L.; Braun, S. B. Tissue distribution of cocaine in the pregnant rat. Life Sci., 1989, 45(14), 1271-1276.
408. Poklis, A.; Mackell, M. A.; Graham, M. Disposition of cocaine in fatal poisoning in man. J. Anal. Toxicol., 1985, 9(5), 227-229.
409. Woods, J. R. Jr.; Plessinger, M. A.; Clark, K. E. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA, 1987, 257(7), 957-961.
410. Koegler, S. M.; Seidler, F. J.; Spencer, J. R.; Slotkin, T. A. Ischemia contributes to adverse effects of cocaine on brain development: suppression of ornithine decarboxylase activity in neonatal rat. Brain Res. Bull., 1991, 27(6), 829-834.
411. Feng, Q. Postnatal consequences of prenatal cocaine exposure and myocardial apoptosis: does cocaine in utero imperil the adult heart? Br. J. Pharmacol., 2005, 144(7), 887-888.
412. Bae, S.; Zhang, L. Prenatal cocaine exposure increases apoptosis of neonatal rat heart and heart susceptibility to ischemia-reperfusion injury in 1-monthold rat. Br. J. Pharmacol., 2005, 144(7), 900-907.
413. Xiao, Y.; Xiao, D.; He, J.; Zhang, L. Maternal cocaine administration during pregnancy induces apoptosis in fetal rat heart. J. Cardiovasc. Pharmacol., 2001, 37(6), 639-648.
414. Li, G.; Xiao, Y.; Zhang, L. Cocaine induces apoptosis in fetal rat myocardial cells through the p38 mitogen-activated protein kinase and mitochondrial/cytochrome c pathways. J. Pharmacol. Exp., 2005, 312(1), 112-119.
415. Pexieder, T. Cell death in the morphogenesis and teratogenesis of the heart. Adv. Anat. Embryol. Cell Biol., 1975, 51(3), 3-99.
416. Feng, Q.; Song, W.; Lu, X.; Hamilton, J. A.; Lei, M.; Peng, T.; Yee, S. P. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation, 2002, 106(7), 873-879.
417. Wencker, D.; Chandra, M.; Nguyen, K.; Miao, W.; Garantziotis, S.; Factor, S. M.; Shirani, J.; Armstrong, R. C.; Kitsis, R. N. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest., 2003, 111(10), 1497-1504.
418. Kajstura, J.; Mansukhani, M.; Cheng, W.; Reiss, K.; Krajewski, S.; Reed, J. C.; Qiaini, F.; Sonnenblick, E. H.; Anversa, P. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp. Cell. Res., 1995, 219(1), 110-121.
419. Fernandez, E.; Siddiquee, Z.; Shohet, R. V. Apoptosis and proliferation in the neonatal murine heart. Dev. Dyn., 2001, 221(3), 302-310.
420. Scarabelli, T. M.; Gottlieb, R. A. Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions. Cell Death Differ., 2004, 11 Suppl 2, S144-S152.
421. Foo, R. S.; Mani, K.; Kitsis, R. N. Death begins failure in the heart. J. Clin. Invest., 2005, 115(3), 565-571.
422. Lee, Y.; Gustafsson, A. B. Role of apoptosis in cardiovascular disease. Apoptosis, 2009, 14(4), 536-548.
423. Sinha-Hikim, I.; Shen, R.; Kovacheva, E.; Crum, A.; Vaziri, N. D.; Norris, K. C. Inhibition of apoptotic signaling in spermine-treated vascular smooth muscle cells by a novel glutathione precursor. Cell Biol. Int., 2010, 34(5), 503-511.
424. Franco, R.; Cidlowski, J. A. Apoptosis and glutathione: beyond an oxidant. Cell Death Differ., 2009, 16(10), 1303-1314.
425. Circu, M. L.; Aw, T. Y. Glutathione and apoptosis. Free Radic. Res., 2008, 42(8), 689-706.
426. Heier, L. A.; Carpanzano, C. R.; Mast, J.; Brill, P. W.; Winchester, P.; Deck, M. D. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. AJNR. Am. J. of Neuroradiol., 1991, 12(5), 951-956.
427. Gomez-Anson, B.; Ramsey, R. G. Pachygyria in a neonate with prenatal cocaine exposure: MR features. J. Comput. Assist. Tomogr., 1994, 18(4), 637-639.
428. Gieron-Korthals, M. A.; Helal, A.; Martinez, C. R. Expanding spectrum of cocaine induced central nervous system malformations. Brain Dev., 1994, 16(3), 253-256.
429. Cohen, M. S.; Bookheimer, S. Y. Localization of brain function using magnetic resonance imaging. Trends Neurosci., 1994, 17(7), 268-277.
430. Cohen, H. L.; Sloves, J. H.; Laungani, S.; Glass, L.; De Marinis, P. Neurosonographic findings in full-term infants born to maternal cocaine abusers: visualization of subependymal and periventricular cysts. J. Clin. Ultrasound, 1994, 22(5), 327-333.
431. Chiriboga, C. A.; Brust, J. C.; Bateman, D.; Hauser, W. A. Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics, 1999, 103(1), 79-85.
432. Bellini, C.; Massocco, D.; Serra, G. Prenatal cocaine exposure and the expanding spectrum of brain malformations. Arch. Intern. Med., 2000, 160(15), 2393.
433. Lewis, B. A.; Singer, L. T.; Short, E. J.; Minnes, S.; Arendt, R.; Weishampel, P.; Klein, N.; Min, M. O. Four-year language outcomes of children exposed to cocaine in utero. Neurotoxicol. Teratol., 2004, 26(5), 617-627.
434. Linares, T. J.; Singer, L. T.; Kirchner, H. L.; Short, E. J.; Min, M. O.; Hussey, P.; Minnes. S. Mental health outcomes of cocaine-exposed children at 6 years of age. J. Pediatr. Psychol., 2006, 31(1), 85-97.
435. Lee, C. T.; Chen, J.; Hayashi, T.; Tsai, S. Y.; Sanchez, J. F.; Errico, S. L.; Amable, R.; Su, T. P.; Lowe, R. H.; Huestis, M. A.; Shen, J.; Becker, K. G.; Geller, H. M.; Freed, W. J. A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med., 2008, 5(6), e117.
436. Lester, B. M.; Padbury, J. F. Third pathophysiology of prenatal cocaine exposure. Dev. Neurosci., 2009, 31(1-2), 23-35.
437. Levitt, P.; Harvey, J. A.; Friedman, E.; Simansky, K.; Murphy, E. H. New evidence for neurotransmitter influences on brain development. Trends in Neurosci., 1997, 20(6), 269-274.
438. Whitaker-Azmitia, P. M. Role of the neurotrophic properties of serotonin in the delay of brain maturation induced by cocaine. Ann. N. Y. Acad. Sci., 1998, 846, 158-164.
439. Mayes, L. C. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev. Psychopathol., 1999, 11(4), 685-714.
440. Malanga, C. J. 3rd.; Kosofsky, B. E. Mechanisms of action of drugs of abuse on the developing fetal brain. Clin. Perinatol., 1999, 26(1), 17-37.
441. Stanwood, G. D.; Levitt, P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr. Opin. Pharmacol., 2004, 4(1), 65-71.
442. Crandall, J. E.; Hackett, H. E.; Tobet, S. A.; Kosofsky, B. E.; Bhide, P. G. Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb. Cortex, 2004, 14(6), 665-675.
443. Kubrusly, R. C.; Bhide, P. G. Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain. Neuropharmacology, 2010, 58(2), 436-443.
444. Guerriero, R. M.; Rajadhyaksha, A.; Crozatier, C.; Giros, B.; Nosten-Bertrand, M.; Kosofsky, B. E. Augmented costitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev. Neurosci., 2005, 27(2-4), 235-248.
445. Bhat, R. V.; Baraban, J. M. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J. Pharmacol. Exp. Ther., 1993, 267(1), 496-505.
446. Novikova, S. I.; He, F.; Bai, J.; Badan, I.; Lidow, I. A.; Lidow, M. S. Cocaineinduced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall. Neurotoxicol. Teratol., 2005, 27(1), 3-14.
447. Gressens, P.; Kosofsky, B. E.; Evrard, P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci. Lett., 1992, 140(1), 113-116.
448. Lidow, M. S.; Song, Z. M. Effect of cocaine on cell proliferation in the cerebral wall of monkey fetuses. Cereb. Cortex, 2001, 11(6), 545-551.
449. Lidow, M. S.; Song, Z. M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J. Comp. Neurol., 2001, 435(3), 263-275.
450. Lidow, M. S. Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse, 1995, 21(4), 332-341.
451. Ren, J. Q.; Malanga, C. J.; Tabit, E.; Kosofsky, B. E. Neuropathological consequences of prenatal cocaine exposure in the mouse. Int. J. Dev. Neurosci., 2004, 22(5-6), 309-320.
452. Friedman, E.; Yadin, E.; Wang, H. Y. Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience, 1996, 70(3), 739-747.
453. Jones, L. B.; Stanwood, G. D.; Reinoso, B. S.; Washington, R. A.; Wang, H. Y.; Friedman, E.; Levitt, P. In utero cocaineinduced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J. Neurosci., 2000, 20(12), 4606-4614.
454. Wang, H. Y.; Runyan, S.; Yadin, E.; Friedman, E. Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J. Pharmacol. Exp. Ther., 1995, 273(1), 492-498.
455. Stanwood, G. D.; Parlaman, J. P.; Levitt, P. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice. J. Comp. Neurol., 2005, 487(3), 270-282.
456. He, N.; Bai, J.; Champoux, M.; Suomi, S. J.; Lidow, M. S. Neurobehavioral deficits in neonatal rhesus monkeys exposed to cocaine in utero. Neurotoxicol. Teratol., 2004, 26(1), 13-21.
457. Lidow, M. S.; Bozian, D.; Song, Z. M. Cocaine affects cerebral neocortical cytoarchitecture in primates only if administered during neocortical neuronogenesis. Brain Res. Dev. Brain Res., 2001, 128(1), 45-52.
458. Thomas, M. J.; Kalivas, P. W.; Shaham, Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol., 2008, 154(2), 327-342.
459. Buttner, A. Review: The neuropathology of drug abuse. Neuropathol. Appl. Neurobiol., 2011, 37(2), 118-134.
460. Alvaro-Bartolomé, M.; La Harpe, R.; Callado, L. F.; Meanac, J. J.; García-Sevilla, J. A. Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats. Neuroscience, 2011, 196, 1-15.
461. Xiao, Y.; He, J. H.; Gilbert, R. D.; Zhang, L. Cocaine induces apoptosis in fetal myocardial cells through a mitochondria-dependent pathway. J. Pharmacol. Exp. Ther., 2000, 292(1), 8-14.
462. Lee, C. T.; Lehrmann, E.; Hayashi, T.; Amable, R.; Tsai, S. Y.; Chen, J.; Sanchez, J. F.; Shen, J.; Becker, K. G.; Freed, W. J. Gene expression profiling reveals distinct cocaine-responsive genes in human fetal CNS cell types. J. Addict. Med., 2009, 3(4), 218-226.
463. Cunha-Oliveira, T.; Rego, A. C.; Garrido, J.; Borges, F.; Macedo, T.; Oliveira, C. R. Neurotoxicity of heroin-cocaine combinations in rat cortical neurons. Toxicology, 2010, 276(1), 11-17.
464. Cunha-Oliveira, T.; Rego, A. C.; Oliveira, C. R. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res. Rev., 2008, 58(1), 192-208.
465. Ackerman, J. P.; Riggins, T.; Black, M. M. A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics, 2010, 125(3), 554-565.
466. García-Fuster, M. J.; Clinton, S. M.; Watson, S. J.; Akil, H. Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse. Neuropsychopharmacology, 2009, 34(5), 1123-1134.